Perceptions and impact of bipolar disorder in Japan: results of an Internet survey

par Watanabe K, Harada E, Inoue T, Tanji Y, Kikuchi T
Publié 2016

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

par Katagiri H, Taketsuna M, Kondo S, Kajimoto K, Aoi E, Tanji Y
Publié 2018

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia

par Katagiri H, Taketsuna M, Kondo S, Kajimoto K, Aoi E, Tanji Y
Publié 2018

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

par Takahashi M, Flynn JA, Tanji Y, Ascher-Svanum H, Ye W, Conley RR
Publié 2012